» Articles » PMID: 39135054

Insights into the ANKRD11 Variants and Short-stature Phenotype Through Literature Review and ClinVar Database Search

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2024 Aug 12
PMID 39135054
Authors
Affiliations
Soon will be listed here.
Abstract

Ankyrin repeat domain containing-protein 11 (ANKRD11), a transcriptional factor predominantly localized in the cell nucleus, plays a crucial role in the expression regulation of key genes by recruiting chromatin remodelers and interacting with specific transcriptional repressors or activators during numerous biological processes. Its pathogenic variants are strongly linked to the pathogenesis and progression of multisystem disorder known as KBG syndrome. With the widespread application of high-throughput DNA sequencing technologies in clinical medicine, numerous pathogenic variants in the ANKRD11 gene have been reported. Patients with KBG syndrome usually exhibit a broad phenotypic spectrum with a variable degree of severity, even if having identical variants. In addition to distinctive dental, craniofacial and neurodevelopmental abnormalities, patients often present with skeletal anomalies, particularly postnatal short stature. The relationship between ANKRD11 variants and short stature is not well-understood, with limited knowledge regarding its occurrence rate or underlying biological mechanism involved. This review aims to provide an updated analysis of the molecular spectrum associated with ANKRD11 variants, investigate the prevalence of the short stature among patients harboring these variants, evaluate the efficacy of recombinant human growth hormone in treating children with short stature and ANKRD11 variants, and explore the biological mechanisms underlying short stature from both scientific and clinical perspectives. Our investigation indicated that frameshift and nonsense were the most frequent types in 583 pathogenic or likely pathogenic variants identified in the ANKRD11 gene. Among the 245 KBGS patients with height data, approximately 50% displayed short stature. Most patients showed a positive response to rhGH therapy, although the number of patients receiving treatment was limited. ANKRD11 deficiency potentially disrupts longitudinal bone growth by affecting the orderly differentiation of growth plate chondrocytes. Our review offers crucial insights into the association between ANKRD11 variants and short stature and provides valuable guidance for precise clinical diagnosis and treatment of patients with KBG syndrome.

References
1.
Hauer N, Popp B, Schoeller E, Schuhmann S, Heath K, Hisado-Oliva A . Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature. Genet Med. 2018; 20(6):630-638. PMC: 5993671. DOI: 10.1038/gim.2017.159. View

2.
Murray N, Burgess B, Hay R, Colley A, Rajagopalan S, McGaughran J . KBG syndrome: An Australian experience. Am J Med Genet A. 2017; 173(7):1866-1877. DOI: 10.1002/ajmg.a.38121. View

3.
Samanta D, Willis E . Electroencephalographic findings in KBG syndrome: a child with novel mutation in ANKRD11 gene. Acta Neurol Belg. 2014; 115(4):779-82. DOI: 10.1007/s13760-014-0413-9. View

4.
Zhang A, Li C, Chen J . Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1. Biochem Biophys Res Commun. 2007; 358(4):1034-40. PMC: 1950474. DOI: 10.1016/j.bbrc.2007.05.017. View

5.
Fu J, Satterstrom F, Peng M, Brand H, Collins R, Dong S . Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet. 2022; 54(9):1320-1331. PMC: 9653013. DOI: 10.1038/s41588-022-01104-0. View